Fat jabs can treat liver disease affecting one in five people, finds trial
FAT jabs can treat a liver disease affecting one in five people, a trial found.
Semaglutide cut inflammation in two thirds of patients with non-alcoholic fatty liver disease.
2
The medicine is used in weight-loss injection Wegovy and diabetes treatment Ozempic.
Fatty liver disease is triggered by excess flab which causes unhealthy fat cells to build up.
It has no specific cure and may cause cancer in later life.
In the study, King's College London looked at the jabs' impact on 800 patients with the disease.
After 18 months, 63 per cent showed a reduction in swelling and fatty build-up in their liver.
They also had healthier blood test results and lost nearly 11 per cent of their weight.
Study author Professor Philip Newsome said: 'This trial will provide real hope for patients.'
What the stages of non-alcoholic fatty liver disease?
THERE are several stages of NAFLD.
Having one stage does not mean you will definitely develop the next one.
Treating NAFLD with a healthy diet, physical activity and weight loss can slow or even reverse it, especially if it is at an earlier stage.
The amount of scarring (fibrosis) in your liver is the main sign of how advanced your NAFLD is. Go to the section about fibrosis tests and scores.
Fatty liver: There is a build-up of fat in your liver but it has not been damaged and there is no scarring. At this point, NAFLD can be fully reversed.
Non-alcohol related steatohepatitis (NASH) with mild fibrosis : Fat is causing inflammation and damage in your liver (hepatitis). There is no or very little scarring. Healthy living can undo the damage and reverse your NAFLD.
NASH with moderate fibrosis: Inflammation and damage have caused some scarring. Your liver is probably still working well and the damage can mostly be repaired.
NASH with advanced fibrosis: There is a lot of scarring. At this stage it is very important to stop further damage and scarring so your NAFLD doesn't get worse. And it is still possible to repair some damage.
Cirrhosis: There is so much scarring it changes the shape of your liver. Your liver can keep working and even repair some damage at this point. But if too much of it becomes scarred, your liver may not be able to carry out its job properly.
Cirrhosis can lead to life-threatening conditions including liver cancer and liver failure.
Source: The British Liver Trust
Everything you need to know about fat jabs
Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases.
Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK.
Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market.
Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year.
How do they work?
The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight.
They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists.
They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high.
Can I get them?
NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics.
Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure.
GPs generally do not prescribe the drugs for weight loss.
Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk.
Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health.
Are there any risks?
Yes – side effects are common but most are relatively mild.
Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea.
Dr Sarah Jarvis, GP and clinical consultant at patient.info, said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.'
Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia.
Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health.
Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Sky News
16 minutes ago
- Sky News
'Life-changing' drug for teenager who lost mother to genetic condition
A teenager who lost her mother, aunt and uncle to a genetic condition is the first person in Europe to receive a "life-changing" drug. Mary Catchpole, 19, from Great Yarmouth, suffers from a rare inherited disorder called activated PI3-Kinase delta syndrome (APDS), which leaves people with a significantly weakened immune system. The condition was passed down by her mother's side of the family, with her mother Sarah dying aged 42 in 2018, while her aunt Helen died aged 12, her uncle Edward when he was 39 and her grandmother Mary when she was 48. APDS patients are vulnerable to repeated infections, causing them to face a lifetime of antibiotics and immunoglobulin replacement therapy to prevent infections and organ damage, and a bone marrow or stem cell transplant - until now. A new drug called leniolisib (Joenja) is a simple tablet taken twice a day and is the first ever targeted treatment for APDS. Ms Catchpole, who is the first person in Europe to receive the medicine after it was made available on the NHS, said taking the new drug is "life-changing" as it means she can leave behind huge amounts of medication. "I was diagnosed with APDS aged seven and it's had a big effect on my life. I had lots of cannulas when I was younger and lots of hospital trips," she said. "I had a permanent line in the side of my body when I was younger, which they put medicine in regularly at the hospital." Ms Catchpole added that she wasn't allowed to do much physical activity, including dancing, which she's "always loved to do". "It has been hard," said the teaching assistant, who lives with her father Jimmy, 64, and her brother Joe, 20, who does not have APDS. The condition was identified by Cambridge researchers in 2013, with Ms Catchpole's family playing a key role in its discovery, as her mother and uncle were both patients at Addenbrooke's Hospital and were offered DNA sequencing to find out whether there was a genetic cause for their immunodeficiency. The researchers found a change in their genes that increased activity of an enzyme called PI3-Kinase delta, meaning this enzyme is effectively "switched on" all the time, preventing immune cells from fighting infection. Professor Sergey Nejentsev, from the University of Cambridge, who led the research that discovered APDS, said: "As soon as we understood the cause of APDS, we immediately realised that certain drugs could be used to inhibit the enzyme that is activated in these patients." The new drug works by inhibiting the PI3-Kinase delta enzyme, effectively normalising the immune system of the patient. "This new drug will make a huge difference to people living with APDS," Dr Anita Chandra, consultant immunologist at Addenbrooke's and affiliated assistant professor at the University of Cambridge, said. Ms Catchpole says she can now look to the future with optimism and lead a normal life. "I really want to become a dance teacher," she said. "I absolutely love my current job as a teaching assistant but I'd also like to go on some adventures as well. I've always felt different so it will be nice to feel like I belong." There are between 40 and 50 people in England who are known to have APDS.
Sky News
16 minutes ago
- Sky News
Areas of England to get extra NHS funding announced
Why you can trust Sky News NHS funding will be diverted to working-class communities, the health secretary is set to announce. Wes Streeting is expected to announce the measure as part of the upcoming NHS 10-year plan, set to be focused on closing health inequalities, during a speech in Blackpool today. About £2.2bn will be spent on staff, medicines, new technology and equipment in rural communities, coastal towns and working-class regions, according to the Department of Health. 3:09 The money, which was previously set aside to plug financial holes in the health service, can now be reinvested where it is "most needed", the department said. It added that NHS leaders have spent months cutting "wasteful" spending, such as on "back office" functions and agency staff, while reducing forecast deficits by health trusts. GP funding will be reviewed under the new plan, as surgeries serving working-class areas receive an average of 10% less funding per patient than practices in more affluent areas. Practices in some of England's poorest areas have about 300 more patients per GP than the most affluent areas, data by the Royal College of GPs suggests. 5:52 The Department of Health said poorer communities had been "neglected" for years and often have the fewest GPs, the worst performing services and the longest waits. Mr Streeting is expected to say during the announcement of the plan that "those in greatest need often receive the worst quality healthcare". He will say that this "flies in the face of the values the NHS was founded on" as "the circumstances of your birth shouldn't determine your worth". Mr Streeting is set to add: "A core ambition of our 10-year plan will be to restore the promise of the NHS, to provide first-class healthcare for everyone in our country and end the postcode lottery." The government "will prioritise investment" where towns have the greatest health needs and the fewest GPs, according to Mr Streeting.
Rhyl Journal
2 hours ago
- Rhyl Journal
Ministers urged to act to protect hospice care for children
Together for Short Lives said hospices are being forced to rely on donations and funds raised from charity shops to prop up services as it called on ministers to increase ring-fenced NHS funding for children's hospices. A new poll of 30 hospices in England found almost nine in 10 (89%) expect their costs to exceed their income this financial year. The charity warned seriously ill children may die without accessing end-of-life care, symptom management and emotional and psychological support as a result. A report from the charity, seen by the PA news agency, states inflation, workforce shortages, and rising demand for care are stretching services to 'breaking point'. The report estimates costs for hospices have risen by 34% since 2021. However, statutory funding for children's hospices is still 'falling short' of what is needed, it adds. 'With reserves set to dwindle and deficits projected to grow, the future of children's hospice care is becoming increasingly unsustainable,' the authors wrote. The report also reveals disparities in funding across England, with neighbouring health authorities spending vastly different amounts on care. Together for Short Lives is urging ministers to increase ring-fenced NHS funding for children's hospices in England from £26 million in 2025/26 to £30 million by 2029/30. It said hospices have said that without this funding they would have to cut back on respite care and short breaks, emotional and psychological support, as well as end-of-life care. Nick Carroll, chief executive of Together for Short Lives, said: 'As ministers try to shift greater levels of healthcare from hospitals into communities, our amazing children's hospices are doing more than ever before to provide crucial support to seriously ill children and their families. 'But as their costs soar, they are having to rely even more on the generosity of the public amid patchy and unsustainable funding from the NHS. 'To expect the complex and often specialist healthcare these families need to be funded by charity shops and donations is wrong – we wouldn't accept this for other parts of our health and care system, so to add more uncertainty to families' lives when many simply don't know how long they have left with their children is unacceptable.' As well as providing end-of-life care, hospices also offer services including emergency support, symptom management and short breaks for respite. One parent described how she 'couldn't live without' the support of her local hospice. Laura McArthur, from Bristol, relies on the Jessie May hospice in the city for support in caring for her seven-year-old son Archie, who has cerebral palsy. But the future of the hospice remains 'unclear' after its charitable expenditure has risen sharply, and uncertainty around funding has forced it to draw on its reserve and rely on voluntary income, Together for Short Lives said. Ms McArthur said: 'Jessie May has known Archie since he was six months old. 'They have been there through it all. 'His needs are so complex, requiring around-the-clock care – at times it can be very difficult. 'Jessie May come and look after Archie so I can have a short break. 'As the years go on, caring for a disabled child is both physically and mentally exhausting. The truth is that I couldn't live without their support.' Mr Carroll added: 'As it finalises its NHS 10-year plan, the UK Government must put in place a long-term, sustainable funding model for children's palliative care in England. 'Immediately, ministers should act to protect and maintain the NHS children's hospice grant and put it on a path to £30 million by 2030. 'Only by doing so can the Government make sure lifeline services are not cut for seriously ill children, which could deny many the choice of accessing end of life care from a children's hospice.' A Department of Health and Social Care spokesperson said: 'The Government recognises the incredible work that children and young people's hospices do across the country. 'We are investing £100 million to improve hospices facilities, and a further £26 million specifically for children's hospices this year, the biggest investment in hospices in a generation. 'We are also working to make sure the palliative and end of life care sector is sustainable in the long-term and are determined to shift more healthcare out of hospitals and into the community through our Plan for Change.'
